Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew B Palmer

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Investigation|October 15, 2021
The key role of NLRP3 and STING in APOL1-associated podocytopathyJunnan Wu, Archana Raman, Nathan J Coffey, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2014
Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practiceSteven J Frank, James D Cox, Michael Gillin, et al.
International Journal of Radiation Oncology, Biology, Physics|December 18, 2018
The Insurance Approval Process for Proton Radiation Therapy: A Significant Barrier to Patient CareMatthew S Ning, Daniel R Gomez, Aashish K Shah, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 5, 2021
Quantification of Glomerular Structural Lesions: Associations With Clinical Outcomes and Transcriptomic Profiles in Nephrotic SyndromeJeffrey B Hodgin, Laura H Mariani, Jarcy Zee, et al.
Nature Medicine|February 21, 2017
Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in micePazit Beckerman, Jing Bi-Karchin, Ae Seo Deok Park, et al.
Glomerular Diseases|November 29, 2023
Cure Glomerulonephropathy Pathology Classification and Core Scoring Criteria, Reproducibility, and Clinicopathologic CorrelationsMatthew B Palmer, Virginie Royal, J Charles Jennette, et al.
The Journal of Biological Chemistry|December 3, 2016
Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal CancerTushar D Bhagat, Yiyu Zou, Shizheng Huang, et al.
Human Pathology|June 18, 2023
Metastatic solid tumors to the testis: a clinicopathologic evaluation of 157 cases from an international collaborationLuiz M Nova-Camacho, Andres M Acosta, Kiril Trpkov, et al.
Science Translational Medicine|February 4, 2026
Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cellsIvan J Cohen, Audrey C Bochi-Layec, Jean Lemoine, et al.
The Lancet. Oncology|June 28, 2024
Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 studyMohamad E Allaf, Se-Eun Kim, Viraj Master, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Investigation|October 15, 2021
The key role of NLRP3 and STING in APOL1-associated podocytopathyJunnan Wu, Archana Raman, Nathan J Coffey, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2014
Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practiceSteven J Frank, James D Cox, Michael Gillin, et al.
International Journal of Radiation Oncology, Biology, Physics|December 18, 2018
The Insurance Approval Process for Proton Radiation Therapy: A Significant Barrier to Patient CareMatthew S Ning, Daniel R Gomez, Aashish K Shah, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 5, 2021
Quantification of Glomerular Structural Lesions: Associations With Clinical Outcomes and Transcriptomic Profiles in Nephrotic SyndromeJeffrey B Hodgin, Laura H Mariani, Jarcy Zee, et al.
Nature Medicine|February 21, 2017
Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in micePazit Beckerman, Jing Bi-Karchin, Ae Seo Deok Park, et al.
Glomerular Diseases|November 29, 2023
Cure Glomerulonephropathy Pathology Classification and Core Scoring Criteria, Reproducibility, and Clinicopathologic CorrelationsMatthew B Palmer, Virginie Royal, J Charles Jennette, et al.
The Journal of Biological Chemistry|December 3, 2016
Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal CancerTushar D Bhagat, Yiyu Zou, Shizheng Huang, et al.
Human Pathology|June 18, 2023
Metastatic solid tumors to the testis: a clinicopathologic evaluation of 157 cases from an international collaborationLuiz M Nova-Camacho, Andres M Acosta, Kiril Trpkov, et al.
Science Translational Medicine|February 4, 2026
Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cellsIvan J Cohen, Audrey C Bochi-Layec, Jean Lemoine, et al.
The Lancet. Oncology|June 28, 2024
Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 studyMohamad E Allaf, Se-Eun Kim, Viraj Master, et al.
Pageof 6